NEWS

Mountainside Medical Center and Eon Partner to Advance Lung Cancer Detection and Improve Patient Outcomes

September 9, 2025

Newswise — MONTCLAIR, N.J. (September 9, 2024) –  Hackensack Meridian Mountainside Medical Center has announced a strategic partnership with Eon, a Denver-based healthtech company, to enhance its lung cancer screening program and improve the identification and management of incidental pulmonary nodules. This collaboration is part of the hospital’s ongoing commitment to early detection and proactive care for patients at risk of lung cancer.

Mountainside’s multidisciplinary lung care team will leverage Eon’s advanced artificial intelligence platform to analyze all complete CT and MRI scans. This technology enables the team to identify potentially cancerous pulmonary nodules earlier and more accurately, even in patients who may not be aware they are at risk.

“Eon’s technology gives us a powerful new tool in the fight against lung cancer,” said Lopa Patel, M.D., medical director of Pulmonary Services at Mountainside Medical Center. “By identifying nodules earlier, we can intervene sooner—when treatment is most effective—and ultimately save more lives.”

Lung cancer remains the leading cause of cancer-related deaths in the United States, accounting for nearly 25% of all cancer fatalities. The disease is often diagnosed at an advanced stage, making early detection critical. Eon’s platform not only supports lung cancer screening but also tracks incidental findings, ensuring that patients receive timely follow-up care.

In addition to its clinical capabilities, Eon’s system automates patient tracking and follow-up reminders, reducing the administrative burden and improving communication between patients and providers.

“At Mountainside, we are committed to expanding access to advanced care for our community,” said Tim O’Brien, CEO of Mountainside Medical Center. “By integrating Eon’s technology into our lung cancer program, we’re not only enhancing our diagnostic capabilities but also ensuring that more patients can benefit from early detection and timely treatment. This partnership reflects our mission to bring the best possible resources to those we serve.”

Eon uses computational linguistics and machine learning to extract clinically relevant data from radiology reports, triaging high-risk patients for provider review while automating tasks for low-risk cases. It is the only solution on the market capable of identifying incidental findings on both CT and MRI scans.

With this partnership, Mountainside Medical Center joins a growing network of healthcare institutions using Eon to transform early disease detection and patient management.

To learn more about Mountainside Medical Center’s Lung Cancer Screening program visit www.mountainsidemedicalcenter.com/lung-cancer.

About Mountainside Medical Center

Mountainside Medical Center has been a trusted provider of healthcare in Montclair and surrounding New Jersey communities since 1891. The hospital is home to specialized centers for imaging, women’s health, cancer care, cardiac care, surgery, weight management, stroke, and chronic kidney disease. Designated as a Primary Stroke Center by the NJ State Department of Health and Senior Services, Mountainside is one of the few community hospitals in the state licensed to perform emergency cardiac angioplasty, offering advanced, life-saving care close to home.

The hospital also features Mountainside Medical Group with expert physicians across primary care and various specialties, ensuring seamless and coordinated care for patients. With conveniently located offices in Montclair, Glen Ridge, Clifton and nearby towns, Mountainside Medical Center makes accessing quality healthcare simple and accessible. To learn more, visit www.mountainsidemedicalcenter.com.